Comparison of Sinus Distribution between Nasal irrigation and Nasal spray Using Fluorescein-labeled in patients with Chronic Rhinosinusitis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20201215004

Enrollment

Registered

2020-12-15

Start date

2020-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intranasal steriod irregation in patients with Chronic Rhinosinusitis Nasal spray&#44

Interventions

NSS 250 ml + 10% fluorescein 10 ml nasal irregation 125 ml per side,Corticosteroid nasal spray + 10% fluorescein 5 ml 2 puff per side

Experimental Device,Experimental Device

Nasal irrigation,Nasal spray

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age > 18 years old Diagnosis of Chronic rhinosinusitis Candidate for endoscopic sinus surgery

Exclusion criteria

Exclusion criteria: History use of cyclosporine U/D : Cystic Fibrosis Pregnancy Previous endoscopic sinus surgery Have reaction from Contrast, sea food Cant follow up

Design outcomes

Primary

Measure	Time frame
Distribution of Fluorescein-labeled 2 years Data record	—

Secondary

Measure	Time frame
None none none	—

Countries

Thailand

Contacts

Public ContactYosita Muenkaew

Faculty of Medicine Ramathibodi Hospital Mahidol University

Yosakidyst@gmail.com0905620442

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Comparison of Sinus Distribution between Nasal irrigation and Nasal spray Using Fluorescein&#45;labeled in patients with Chronic Rhinosinusitis